Glucose Bp B. Braun Melsungen (Glucose Monohydrate)

Glucose Bp B. Braun Melsungen is employed in several clinical situations where rapid glucose supplementation or fluid replacement is required.

• Treatment of acute hypoglycemia to quickly raise plasma glucose levels.
• Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
• Fluid and electrolyte replacement in perioperative or trauma care.
• Support of carbohydrate needs during prolonged fasting or critical illness.
• Dilution medium for certain intravenous drug preparations.

Intravenous administration of glucose monohydrate may be associated with a range of physiological responses, most of which are predictable and dose‑related.

Common

• Transient hyperglycemia with elevated blood glucose measurements.
• Mild nausea or abdominal discomfort.
• Local irritation or redness at the infusion site.
• Electrolyte shifts, particularly decreased serum potassium.
• Fluid overload in patients with compromised cardiac function.
• Headache or dizziness due to rapid osmotic changes.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypersensitivity reactions such as rash, urticaria, or anaphylaxis.
• Hyperosmolar hyperglycemic state in susceptible patients.
• Metabolic acidosis associated with extreme hyperglycemia.

When using Glucose Bp B. Braun Melsungen, clinicians should evaluate patient-specific factors and monitor relevant parameters to minimize risks.

• Assess baseline blood glucose and adjust infusion rate accordingly.
• Use caution in patients with diabetes mellitus or impaired glucose tolerance.
• Monitor fluid balance in individuals with heart failure or renal insufficiency.
• Check serum electrolytes, especially potassium and sodium, before and during therapy.
• Avoid rapid infusion in neonates and low‑birth‑weight infants.
• Consider compatibility with other intravenous solutions to prevent precipitation.
• Discontinue if signs of hypersensitivity or severe hyperglycemia develop.

Glucose monohydrate can interact with other medications or solutions administered intravenously, influencing efficacy or safety.

Avoid

• Co‑administration with high‑dose insulin without appropriate glucose monitoring.
• Mixing with calcium‑containing solutions that may precipitate.
• Concurrent use of diuretics that exacerbate electrolyte disturbances.

Use with caution

• Concurrent administration of potassium‑sparing agents; monitor serum potassium.
• Use alongside beta‑blockers in diabetic patients, as they may mask hypoglycemia symptoms.
• Combination with other hyperosmolar solutions; observe for fluid overload.